Regeneron Pharmaceuticals has received accelerated FDA approval for Lynozyfic, a new bispecific antibody treatment for adults with relapsed or refractory multiple myeloma who have undergone at least ...

The approval was supported by pooled data from 2 open-label, single arm trials: the phase 2 NI-0501-06 study and the phase 3 EMERALD trial.

The last two years have seen some newly enacted state policies cast aside in short order, followed by a reversion to more ...

Substance use was implicated in more than half of all adult drownings in baths or hot tubs in the last 10 years, according to ...

The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65, effectively limiting their availability later ...

The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received previous treatment, the drugmaker said on Wednesday.

Vaping rates among teens and young adults have climbed sharply in recent years. In 2023, nearly 1 in 4 young adults vaped. By 2024, about 8% of high school students reported vaping.

For every category of prescription drug Garcia examined — stimulants like Adderall, tranquilizers like Xanax and pain relievers like Oxycontin — misuse was highest among those with cognitive and ...

We saw the highest rates of drug misuse among adults with cognitive disabilities and young adults, and pain relievers were the most misused drug." Jeanette Garcia, associate professor, WVU College ...

For decades, doctors told healthy older adults to take an over-the-counter drug daily to prevent heart attack or stroke. The guidance has since changed — but many older adults are still taking it.

Key Takeaways Tirzepatide is approved for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity, alongside diet and exercise. The SURMOUNT-OSA trial showed significant reductions ...